What Does SALIX DATA Do?

Total employees126
HeadquartersBridgewater
Founded1999

Salix Pharmaceuticals is a specialty pharmaceutical company committed to the prevention and treatment of gastrointestinal diseases. Since its acquisition by Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals) in 2015, Salix has operated as a significant gastroenterology (GI) business unit. The company develops and markets a portfolio of innovative products aimed at treating conditions such as irritable bowel syndrome with diarrhea (IBS-D), hepatic encephalopathy (HE), opioid-induced constipation (OIC), and traveler's diarrhea. Salix's mission is to improve patients' lives by providing healthcare professionals with effective GI solutions, driven by research and a deep understanding of digestive health.

Where Is SALIX DATA's Headquarters?

HQ Function

Serves as the central hub for Salix's strategic, operational, and commercial activities within the Bausch Health framework, overseeing its gastroenterology product portfolio, R&D direction, and market strategies.

Notable Features:

Located in a modern corporate office park, facilitating collaboration and innovation. The campus offers state-of-the-art amenities typical of a leading pharmaceutical company headquarters.

Work Culture:

As part of Bausch Health, the work culture is likely focused on performance, innovation in healthcare, and a commitment to patient well-being. Emphasis is placed on scientific rigor and commercial execution in the pharmaceutical sector.

HQ Significance:

The Bridgewater headquarters is crucial for integrating Salix's specialized GI expertise with Bausch Health's broader resources, enabling effective management and growth of its product lines like XIFAXAN®, TRULANCE®, and RELISTOR®.

Values Reflected in HQ: The headquarters reflects values of collaboration, innovation, efficiency, and a strong focus on addressing unmet needs in gastroenterological health.

Location:

While Salix Pharmaceuticals primarily focuses on the U.S. market for its gastroenterology products, its innovations and treatments reach patients globally through the extensive international infrastructure and distribution network of its parent company, Bausch Health. Bausch Health supports commercial operations, regulatory affairs, and market access in numerous countries worldwide, allowing Salix's GI therapies to benefit a broader patient population.

Street Address:

400 Somerset Corporate Blvd

City:

Bridgewater

State/Province:

New Jersey

Country:

USA

Where Else Does SALIX DATA Operate Around the World?

Raleigh, North Carolina/USA

Address: 8510 Colonnade Center Dr, Raleigh, NC 27615, USA (Bausch Health Office)

Acts as a significant operational and R&D site, capitalizing on the region's strong pharmaceutical and biotech ecosystem and historical ties to Salix's legacy operations.

Buying Intent Signals for SALIX DATA

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading SALIX DATA? Meet the Executive Team

As of April 2025, SALIX DATA' leadership includes:

Thomas J. Appio - Chief Executive Officer, Bausch Health (Parent Company)
John S. Barone - Executive Vice President & President, Diversified Products, Bausch Health (Segment includes Salix)
Yehia Hashad - Executive Vice President of Research and Development and Chief Medical Officer, Bausch Health

Who's Investing in SALIX DATA?

SALIX DATA has been backed by several prominent investors over the years, including:

As Salix Pharmaceuticals is a wholly-owned subsidiary of Bausch Health Companies Inc. (NYSE: BHC, TSX: BHC), its investors are the shareholders of Bausch Health.
Major institutional investors of Bausch Health include Icahn Capital LP, Paulson & Co. Inc., The Vanguard Group, Inc., and BlackRock, Inc.

What Leadership Changes Has SALIX DATA Seen Recently?

Hire1
Exits1

Bausch Health has experienced key leadership appointments in the past year impacting segments that include Salix Pharmaceuticals. Notable changes include a new head for the Diversified Products segment.

Departures

Nicola Kayel, Nicola Kayel departed from her role as SVP/General Manager for Salix Pharmaceuticals at Bausch Health.

New Appointments:

John S. Barone, John S. Barone was appointed as EVP & President, Diversified Products at Bausch Health, with Salix Pharmaceuticals falling under his leadership.

What Technology (Tech Stack) Is Used bySALIX DATA?

Discover the tools SALIX DATA uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

SALIX DATA Email Formats and Examples

As Salix Pharmaceuticals is a division of Bausch Health, employees typically use the @bauschhealth.com email domain. Common corporate email formats include [first].[last]@bauschhealth.com and [first_initial][last]@bauschhealth.com.

[first].[last]@bauschhealth.com or [first_initial][last]@bauschhealth.com

Format

john.smith@bauschhealth.com or jsmith@bauschhealth.com

Example

80%

Success rate

What's the Latest News About SALIX DATA?

Bausch Health Press ReleasesMay 7, 2024

Bausch Health Reports First-Quarter 2024 Financial Results, Salix Segment Shows Growth

Bausch Health announced its Q1 2024 financial results, reporting consolidated revenues of $2.15 billion. The Salix segment reported revenues of $512 million, a 6% increase compared to Q1 2023, primarily driven by growth in XIFAXAN®....more

Bausch Health Press ReleasesFebruary 22, 2024

Bausch Health Reports Fourth-Quarter and Full-Year 2023 Financial Results

Bausch Health released its Q4 and full-year 2023 financial results. For the full year, the Salix segment reported revenues of $2.088 billion, demonstrating continued performance of its key gastroenterology products....more

Salix Pharmaceuticals NewsOctober 23, 2023

Salix Pharmaceuticals Highlights New XIFAXAN® (Rifaximin) Data and Educational Initiatives at ACG 2023

Salix Pharmaceuticals announced it would be presenting nine scientific posters, including new data on XIFAXAN® (rifaximin), at the American College of Gastroenterology (ACG) 2023 Annual Scientific Meeting. This underscores their commitment to advancing GI care....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including SALIX DATA, are just a search away.